Near-Complete Pathological Response to Abemaciclib in the Treatment of Well-Differentiated/Dedifferentiated Liposarcoma: A Case Report

Article Tools CASE REPORTS Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/PO.21.00482 JCO Precision Oncology no. 7 (2023) e2100482. Published online June 21, 2023. PMID: 37343202 Near-Complete Pathological Response to Abemaciclib in the Treatment of Well-Differentiated/Dedifferentiated Liposarcoma: A Case Report Nicholas C. Neel , BA, BS1xNicholas C. NeelSearch for articles by this author; Jason K. Sicklick , MD1,2,3xJason K. SicklickSearch for articles by this author; Somaye Zare, MD1,4xSomaye ZareSearch for articles by this author; and Sarah G. Boles , MD1,2,5xSarah G. BolesSearch for articles by this author Show More 1University of California, San Diego School of Medicine, San Diego, CA2UC San Diego Moores Cancer Center, La Jolla, CA3Department of Surgery, Division of Surgical Oncology, UC San Diego Health, San Diego, CA4Department of Pathology, UC San Diego Health, San Diego, CA5Department of Medicine, Division of Medical Oncology, UC San Diego Health, San Diego, CA https://doi.org/10.1200/PO.21.00482 First Page Full Text PDF Figures and Tables © 2023 by American Society of Clinical OncologyAUTHOR CONTRIBUTIONSConception and design: Nicholas C. Neel, Jason K. SicklickCollection and assembly of data: All authorsData analysis and interpretation: All authorsManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTThe following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/po/author-center.Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).Jason K. SicklickStock and Other Ownership Interests: PersonalisConsulting or Advisory Role: Deciphera, EthiconSpeakers' Bureau: QED Therapeutics, Foundation Medicine, Roche, Deciphera, MJH Life Sciences, MerckResearch Funding: Foundation Medicine, AmgenNo other potential conflicts of interest were reported.